Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Doki, Noriko  [Clear All Filters]
2019
Konuma, T., Kondo, T., Mizuno, S., Doki, N., Aoki, J., Fukuda, T., Tanaka, M., Sawa, M., Katayama, Y., Uchida, N., et al. (2019). Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission.Biol Blood Marrow Transplant.
Tanaka, K., Toyota, S., Akiyama, M., Wakimoto, N., Nakamura, Y., Najima, Y., Doki, N., Kakihana, K., Igarashi, A., Kobayashi, T., et al. (2019). Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.Acta Haematol141, 111-118.
Kurosawa, S., Sekiya, N., Doki, N., Yaguchi, T., Kishida, Y., Nagata, A., Yamada, Y., Konishi, T., Kaito, S., Yoshifuji, K., et al. (2019). The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.Int J Infect Dis.
Ohwada, C., Sakaida, E., Igarashi, A., Kobayashi, T., Doki, N., Mori, T., Kato, J., Koda, Y., Kanamori, H., Tanaka, M., et al. (2019). A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.Biol Blood Marrow Transplant.
Suzuki, K., Doki, N., Meguro, K., Sunami, K., Kosugi, H., Sasaki, O., Takagi, T., Murakami, H., and Shimizu, K. (2019). Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem.Int J Hematol.
Konishi, T., Doki, N., Nagata, A., Yamada, Y., Takezaki, T., Kaito, S., Kurosawa, S., Sakaguchi, M., Harada, K., Yasuda, S., et al. (2019). Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia.Ann Hematol.